Pembrolizumab Shows Durable Response in Advanced Unresectable Anal Cancer
Van K. Morris, MD, discusses the findings of the KEYNOTE-158 trial, which evaluated pembrolizumab in advanced solid tumors in relation to patients with advanced unresectable anal cancer.
Discussing the Novel Treatments in Colorectal and Anal Cancer
Van K. Morris, MD, describes the novel treatments he is excited about in the treatment landscapes for colorectal and anal cancers right now.